ArticleJournal of Alzheimer's disease : JAD2023

Evaluation of Blood-Based Plasma Biomarkers as Potential Markers of Amyloid Burden in Preclinical Alzheimer's Disease.

Charisse N Winston et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.